Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Auteur de référence en rhumatologie
50 articles scientifiques publiés — un praticien à la pointe de la recherche
✨ Génération du profil synthétique IA en cours…
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
The Journal of rheumatology · 2025
ObjectiveBosentan (BOS) is approved for treating pulmonary arterial hypertension (PAH) and preventing digital ulcers (DU) in systemic sclerosis (SSc). Our study aimed to evaluate whether BOS prescribed for DU could reduce the incidence of PAH in a large SSc cohort from the Systemic Sclerosis Progression Investigation (SPRING) registry.MethodsPatients with SSc from the SPRING registry, meeting 2013 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria with data on PAH onset, DU status, BOS exposure, and at least 1 year of follow-up between 2015 and 2020, and having no known PAH at baseline, were included. PAH was diagnosed with right heart catheterization during the follow-up, and its incidence rate (IR) was calculated. Kaplan-Meier curves were determined, and multivariate regression identified PAH risk factors.ResultsAmong 727 eligible patients with SSc, followed for a median of 2.0 years, 54 (7.4%) developed PAH (IR 3.71 per 100 patient-years [PYs]). Patients with DU who were never exposed to BOS had a higher incidence of PAH (IR 4.90 per 100 PYs) compared to those exposed to BOS, whose rates matched those without DU and who were never exposed to BOS. Risk factors independently associated with PAH development included DU (hazard ratio [HR] 1.86), age (HR 1.05), modified Rodnan skin score > 4 (HR 2.07), interstitial lung disease (HR 2.29), and acetylsalicylic acid treatment (HR 1.78).ConclusionIn our cohort, the presence of DU was confirmed as a leading risk factor for PAH development, and BOS use for DU prevention may reduce this risk. Only patients with DU who were not using BOS had an increased PAH incidence.
BMC women's health · 2025
Abstract Background The low use of self-injectable contraception, coupled with the recognition that many individuals need support beyond training to use self-care technologies successfully, suggests the need for innovative programming. We describe the participatory human-centered design process we used in two districts of Uganda to develop a community-based peer support intervention to improve women’s agency to make and act on contraceptive decisions and help diffuse self-injectable contraception. Methods The design team included multi-disciplinary researchers from Uganda and the United States, representatives of local community-based organizations and village health teams, and local women of reproductive age. The research group conducted 21 in-depth interviews, 12 observations, and six focus group discussions to understand women’s social support needs, contraceptive-seeking experiences, and communication channels. From these data, the design team derived insights into needs and opportunities to improve contraceptive agency and support self-injection use among interested women, spurring a creative idea-generation process to develop a large set of potential solutions. We collectively prioritized the most promising ideas into an integrated, theoretically informed intervention and subsequently prototyped, tested, and refined the intervention. Results Design insights included: women value information from experienced peers and want support to navigate uneven partner dynamics, conflicting contraceptive information, concerns about contraceptive-related side effects, and unreliable contraception services. The final intervention—called I-CAN (English) , Nsobola (Lusoga) , An Atwero (Langi)—engages experienced self-injection users as ‘mentors’ to support other women (‘mentees’) they recruit in community-based settings. Mentors provide informational, instrumental, appraisal, and emotional support tailored to the individual needs of mentees. This support is designed to improve mentees’ knowledge, consciousness of their rights related to contraception, self-efficacy, and perceived control related to contraceptive decision-making, self-injection self-efficacy, contraceptive access, and ability to act on preferences. Conclusions Our iterative human-centered design process incorporated diverse, lived experiences and scientific expertise and resulted in a peer support intervention with the potential to fill an important gap in contraception service delivery in Uganda. Our approach demonstrates that creating complex interventions to prioritize support for women’s agency related to contraception in line with a human rights-based approach and to spread new contraceptive methods is feasible.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Frontiers in immunology · 2026 · Published Erratum
Zheng L, A X, Ma S, Xu B, et al.
Clinical colorectal cancer · 2026 · Journal Article
Persiani R, Tirelli F, Lorenzon L, Neri I, et al.
Frontiers in immunology · 2026 · Published Erratum
Zheng L, A X, Ma S, Xu B, et al.
Frontiers in immunology · 2026 · Journal Article
A X, Xin P, Zheng L, Xu B, et al.
Nutrients · 2026 · Journal Article
Ulambayar B, Ágnes B, Móré M, Nagy AC
Cancer epidemiology · 2026 · Journal Article
Nicolas M, Agnès R, Christophe B, Julie S, et al.
Frontiers in immunology · 2025 · Journal Article
Zheng L, A X, Ma S, Xu B, et al.
Cancers · 2025 · Journal Article
Fertitta V, Escobar Marcillo DI, Privitera GF, Del Cornò M, et al.
Journal of diabetes science and technology · 2025 · Journal Article
Agnes T, Maiya GA, Kulakarni MM, Hegde SR, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2025 · English Abstract
Janzen S, Saxena P, Agnes C, Maaß W
Chinese medicine · 2025 · Journal Article
Bian Y, Li F, A X, Xiang Z, et al.
Scientific reports · 2025 · Journal Article
M C S, B K, A U, K C S
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025 · Journal Article
Angelico R, Trapani S, Manzia TM, Lenci I, et al.
World journal of transplantation · 2025 · Journal Article
Pascale MM, Frongillo F, Vasta P, Massimiani G, et al.
BMC veterinary research · 2025 · Journal Article
A S, S AP, J M, P C, et al.
International journal of biological macromolecules · 2025 · Journal Article
Agnes CJ, Li L, Bertrand D, Murshed M, et al.
BMC women's health · 2025 · Journal Article
Birabwa C, Phillips B, Amongin D, Atuyambe L, et al.
Cureus · 2025 · Journal Article
N M, A NT, Muruganandan R, Vellingiri K
Frontiers in immunology · 2025 · Journal Article
A X, Xin P, Zheng L, Xu B, et al.
World journal of surgical oncology · 2025 · Journal Article
Santocchi P, Agnes A, Biondi A
Journal of Crohn's & colitis · 2025 · Journal Article
Mesonero F, Alicia LG, José MB, Cristina RC, et al.
Journal of microbiological methods · 2025 · Journal Article
Frederic B, Vincent B, Agnes R, Xavier L, et al.
RMD open · 2026 · Journal Article
Batani V, Cavazzana I, Orlandi M, De Angelis R, et al.
Rheumatology (Oxford, England) · 2026 · Journal Article
Bonomi F, Bruni C, Peretti S, De Angelis R, et al.
PloS one · 2025 · Journal Article
Moposita Molina FD, Agnes G, Zandoná MR, Izquierdo R, et al.
World journal of gastrointestinal surgery · 2026 · Journal Article
Pascale MM, Gervasoni J, Bianco G, Persichilli S, et al.
Healthcare (Basel, Switzerland) · 2025 · Journal Article
Kurnianto AA, Kovács S, Ágnes N, Kumar P
Cancers · 2025 · Journal Article
Pascale MM, Marandola C, Frongillo F, Nure E, et al.
Frontiers in immunology · 2025 · Clinical Trial, Phase II
Agnes JT, Marcus SA, Al-Ghraibeh SS, Al-Sweedan SA, et al.
Food research international (Ottawa, Ont.) · 2025 · Journal Article
Sandrine G, Agnès BA, Sandrine R, Nabila H
Nature medicine · 2025 · Journal Article
Tebas P, Patel A, Agnes JT, Parzych EM, et al.
World journal of gastrointestinal surgery · 2026 · Journal Article
Pascale MM, Gervasoni J, Bianco G, Persichilli S, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2026 · Journal Article
Xin P, Li W, A X, Shen J, et al.
Healthcare (Basel, Switzerland) · 2025 · Journal Article
Kurnianto AA, Kovács S, Ágnes N
Healthcare (Basel, Switzerland) · 2025 · Journal Article
Kurnianto AA, Kovács S, Ágnes N, Kumar P
Updates in surgery · 2025 · Journal Article
Agnes A, Biondi A, Carannante M, Strippoli A, et al.
Cureus · 2025 · Journal Article
Muraleedharan A, Chaubey S, A S, Yadav A
Therapeutic advances in musculoskeletal disease · 2026 · Journal Article
Peretti S, Bruni C, Bonomi F, De Angelis R, et al.
Rheumatology (Oxford, England) · 2026 · Journal Article
De Angelis R, Ferri C, Cipolletta E, Riccieri V, et al.
Clinical rheumatology · 2025 · Journal Article
A K, M EA, M H, H A, et al.
Journal of autoimmunity · 2025 · Journal Article
Tonutti A, Motta F, Bajocchi G, Bellando-Randone S, et al.
World journal of surgical oncology · 2025 · Journal Article
Agnes A, Boldrini L, Perillo F, Tran HE, et al.
Archives of osteoporosis · 2025 · Journal Article
N BV, A MS, A DR, H SG, et al.
Cancers · 2025 · Journal Article
Pascale MM, Marandola C, Frongillo F, Nure E, et al.
World journal of transplantation · 2025 · Journal Article
Biolato M, Miele L, Avolio AW, Marrone G, et al.
Therapeutic advances in musculoskeletal disease · 2025 · Journal Article
Orlandi M, Giuggioli D, Ferri C, De Angelis R, et al.
Clinical rheumatology · 2025 · Journal Article
Orlandi M, De Luca G, Ferri C, Spinella A, et al.
The Journal of rheumatology · 2025 · Journal Article
Cacciapaglia F, De Angelis R, Ferri C, Bajocchi G, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2025 · Journal Article
Manzia TM, Trapani S, Nardi A, Ricci A, et al.
JMIR research protocols · 2025 · Journal Article
M A, Ahmad A, A A, Raj LS, et al.
Arthritis care & research · 2025 · Journal Article
De Lorenzis E, Natalello G, De Angelis R, Verardi L, et al.
Journal of autoimmunity · 2025 · Journal Article
Tonutti A, Motta F, Bajocchi G, Bellando-Randone S, et al.
European journal of clinical investigation · 2025 · Journal Article
Tonutti A, Motta F, De Angelis R, Cipolletta E, et al.
Journal of clinical medicine · 2025 · Journal Article
Schirra E, Mauro A, Bianco G, Pascale MM, et al.
✨ Profil synthétique
IA · 19/05/2026MME Agnès MOUTON-GENSBURGER est une rhumatologue dont les publications PubMed couvrent divers aspects de la rhumatologie, notamment l'épidémiologie, la pharmacovigilance et l'économie de la santé. Ses travaux portent également sur les biomarqueurs et les auto-anticorps, ainsi que sur la qualité de vie et les mesures de résultats rapportés par les patients (PROMs).
Expertises présumées
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.